The FDA has classified the recall as its most serious, warning that continued use without intervention could result in serious injury or death, according to a Feb. 21 agency news release.
The recall affects several pacemaker models: Accolade, Proponent, Essentio, Altrua 2, Visionist and Valitude. Boston Scientific has advised healthcare providers to monitor affected patients closely and to schedule device replacements when necessary.
A total of 832 injuries and two deaths related to the device have been reported, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.